IntelGenx Technologies Corp. (CVE:IGX – Get Free Report)’s stock price traded up 1.8% on Friday . The stock traded as high as C$0.60 and last traded at C$0.58. 11,848 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 56,279 shares. The stock had previously closed at C$0.57.
IntelGenx Technologies Stock Up 1.8 %
The company has a debt-to-equity ratio of 164.62, a current ratio of 2.77 and a quick ratio of 2.69. The firm’s 50 day moving average is C$0.58 and its two-hundred day moving average is C$0.58. The firm has a market capitalization of C$87.32 million and a P/E ratio of -7.44.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
Featured Stories
- Five stocks we like better than IntelGenx Technologies
- Investing in the High PE Growth Stocks
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Penny Stocks Ready to Break Out in 2025
- Stock Market Upgrades: What Are They?
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
